Display options
Share it on

Natl Sci Rev. 2020 Oct 12;8(1):nwaa257. doi: 10.1093/nsr/nwaa257. eCollection 2021 Jan.

A proposal for clinical trials of COVID-19 treatment using homo-harringtonine.

National science review

Hai-Jun Wen, Feng-Liang Liu, Ming-Xing Huang, Rong-Hua Luo, Wen-Bin He, Jing Feng, Fang-Liang Chen, Qi-Chun Cai, Hua-Juan Ma, Zi-Feng Yang, Xi Zhou, You Shang, Xue-Mei Lyu, Ding-Yu Zhang, Fei Xiao, Hong Shan, Jian-Xing He, Yong-Tang Zheng, Chung-I Wu

Affiliations

  1. State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, China.
  2. Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, China.
  3. Department of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-sen University, China.
  4. State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, China.
  5. Kunming Police Dog Base of the Ministry of Public Security, China.
  6. Cancer Center, Clifford Hospital, Jinan University, China.
  7. National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease (Guangzhou Medical University), China.
  8. Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, China.
  9. Joint Laboratory of Infectious Diseases and Health, Wuhan Institute of Virology and Wuhan Jinyintan Hospital, China.
  10. Center for Translational Medicine, Wuhan Jinyintan Hospital, China.
  11. Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, China.

PMID: 34676091 PMCID: PMC7665622 DOI: 10.1093/nsr/nwaa257

[No abstract available.]

References

  1. Antiviral Res. 2015 Feb;114:1-10 - PubMed
  2. Lancet. 2020 May 30;395(10238):1695-1704 - PubMed
  3. Viruses. 2018 Nov 01;10(11): - PubMed
  4. Nature. 2014 Sep 25;513(7519):517-22 - PubMed
  5. Function (Oxf). 2020;1(1):zqaa002 - PubMed
  6. Emerg Infect Dis. 2020 Jul;26(7):1592-1595 - PubMed
  7. Chest. 2020 Jul;158(1):e9-e13 - PubMed
  8. J Aerosol Med Pulm Drug Deliv. 2011 Dec;24(6):261-70 - PubMed
  9. Eur J Biochem. 1977 Jan;72(2):323-30 - PubMed
  10. Nat Med. 2020 May;26(5):672-675 - PubMed
  11. Oncologist. 2014 Jan;19(1):94-9 - PubMed
  12. Chin Med J (Engl). 1976 Jul;2(4):263-72 - PubMed
  13. Nature. 2020 Jul;583(7816):459-468 - PubMed
  14. Viruses. 2019 Oct 18;11(10): - PubMed
  15. BMJ. 2020 May 14;369:m1849 - PubMed
  16. Antiviral Res. 2020 Jun;178:104786 - PubMed
  17. N Engl J Med. 2020 May 7;382(19):1787-1799 - PubMed
  18. Nature. 2020 May;581(7809):465-469 - PubMed
  19. N Engl J Med. 2020 Nov 5;383(19):1827-1837 - PubMed
  20. Cancer. 2001 Sep 15;92(6):1591-605 - PubMed
  21. Cancer Chemother Pharmacol. 2013 Jan;71(1):35-41 - PubMed
  22. Antimicrob Agents Chemother. 2013 Jan;57(1):155-67 - PubMed
  23. BMJ. 2020 Jul 30;370:m2980 - PubMed

Publication Types